Carl Zeiss plays an active role in the combat of TB worldwide and is a member of the Stop TB Initiative of the World Health Organization (WHO). The WHO founded this programme in 2006 with the aim of eliminating TB by 2050. Carl Zeiss, together with the Swiss Foundation for Innovative New Diagnostics (FIND), developed the Primo Star iLED.
Carl Zeiss delivered over 1200 of these iLED microscopes to Ethiopia in February. Further orders arrived recently from Bangladesh, Myanmar, Nigeria and Pakistan. Last year, they delivered over 1800 microscopes to TBs centers in the affected regions.
One aspect of the collaboration between Carl Zeiss and FIND is to allow health facilities in the worst-hit countries to obtain Primo Star iLED at a greatly reduced price. Carl Zeiss is also involved in the International Union against Tuberculosis and Lung Disease, which holds the Union Conference every year.
Currently, around one third of the world’s population is infected with TB pathogens. The fluorescence microscope supports medical personnel in remote regions in the fast and reliable diagnosis of TB on site. Due to its energy-saving LED illumination and high performance batteries, Primo Star iLED may also be used in areas with no power supply.